MercadoLibre arrives at its July 31 earnings date in a notably different position than it occupied two months ago — the stock is up 18% in a month, analysts are nudging targets back up, and short sellers have been quietly retreating.
The most striking development this week is the pace of the recovery. After May's bruising earnings reaction — the stock fell 11% the day after Q1 results and shed nearly 13% over the following five sessions — MELI has spent most of June and July rebuilding. It closed Tuesday at $1,873.88, up 3.3% on the week and nearly 18% over the past month. That kind of rebound, headed into a fresh print on July 31, sets up an interesting tension: options traders are not yet pricing in the same level of defensiveness that appeared before May's miss.
The positioning data supports a cautiously constructive lean. Short interest has edged higher on the week, rising about 5% to roughly 1.9% of the free float — still a low absolute level. The borrow market is wide open, with availability running at essentially maximum capacity, meaning no supply constraint exists for new shorts even as some positions rebuild. Cost to borrow has been drifting down, now near 0.47%, about 15% below last week's level. Options sentiment is mildly more defensive than its recent baseline — the put/call ratio at 0.89 sits about 0.8 standard deviations above the 20-day mean of 0.87 — but the reading is nowhere near the anxiety levels seen at the 52-week high of 1.34. Overall, positioning looks cautious but not crowded.
The Street's story is one of selective re-engagement after a post-earnings de-rating. Citigroup, which downgraded MELI to Neutral and cut its target from $2,200 to $1,950 in May, this week raised that target back to $2,000 — a signal that the analyst who pulled the most visible negative trigger is incrementally less bearish. After May's results, targets fell broadly: Morgan Stanley trimmed from $2,600 to $2,450, Barclays from $2,500 to $2,300, and JPMorgan from $2,100 to $1,900. The consensus mean target remains at $2,207 — implying around 18% upside from current levels — with Morgan Stanley and Barclays holding Overweight ratings and BTIG reiterating Buy at $2,150. Bears point to near-term margin pressure from accelerated credit card issuance and the risk of macro deterioration across Latin America. Bulls counter that a maturing credit cohort represents up to $2B in latent earnings contribution, and that MELI's dual platform — Mercado Libre for commerce, Mercado Pago for fintech — remains structurally dominant. The EV/EBITDA multiple has been compressing, down roughly 0.3 turns in 30 days, while the P/E of 32x and P/B near 7.9x reflect a growth premium that is still demanding but has eased since the May selloff. Forward EPS momentum ranks in the 86th percentile of the universe on a 12-month basis, suggesting the analyst community still expects meaningful earnings expansion.
Institutional ownership adds context to the recovery bid. Capital Research and Management, the largest holder at 13.3% of shares, added nearly 978,000 shares in the period ending June 30 — a meaningful incremental commitment from a long-term holder. Baillie Gifford sits at 6.4% of shares with minimal recent movement. Insider activity has been modest but directionally positive: the Chief Accounting Officer picked up 125 shares in June near $1,605, and an independent director bought roughly 600 shares in May around $1,656 — all near the post-earnings lows. These are small in dollar terms but consistent with a pattern of insiders buying weakness.
The shape of the next catalyst — July 31 results — is what the data now points toward. The prior two prints produced a day-one drop of 11% and a modest 1.5% decline. Whether the Street's repositioned targets and rebuilt long interest have already priced in a more conservative outcome, or whether guidance on credit quality and fintech margin recovery becomes the new fault line for the next leg, is the question worth watching into month-end.
See the live data behind this article on ORTEX.
Open MELI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
